A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects

NCT04032782 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacology

Interventions

DRUG: HM15136
DRUG: Placebo of HM15136

Sponsor

Hanmi Pharmaceutical Company Limited